In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: Comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder

Journal of Clinical Microbiology

Volumn 46, Issue 10, 2008, Pages 3477-3478

  Lalitha, P ^a   Vijaykumar, R ^a   Prajna, N V ^a   Fothergill, A W ^b  

^a ARAVIND EYE HOSPITAL   (India)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATAMYCIN;

ARTICLE; ASPERGILLUS; DRUG ACTIVITY; DRUG FORMULATION; DRUG SENSITIVITY; FUSARIUM; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; ASPERGILLUS; EYE INFECTIONS, FUNGAL; FUSARIUM; HUMANS; MICROBIAL SENSITIVITY TESTS; NATAMYCIN; OPHTHALMIC SOLUTIONS; POWDERS;

ASPERGILLUS; FUSARIUM;

EID: 53649090786     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00610-08     Document Type: Article

References (17)

1. Bharathi, M. J., R. Ramakrishnan, S. Vasu, R. Meenakshi, and R. Palaniappan. 2003. Epidemiological characteristics and laboratory diagnosis of fungal keratitis: a three-year study. Indian J. Ophthalmol. 51:315-321.
2. Brooks, D. E., S. E. Andrew, C. L. Dillavou, G. Ellis, and P. S. Kubilis. 1998. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis. Am. J. Vet. Res. 59:138-142.
3. Clinical and Laboratory Standards Institute. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard; document M38-A. CLSI, Wayne, PA.
4. Forster, R. K., and G. Rebell. 1975. The diagnosis and management of keratomycoses. Arch. Ophthalmol. 93:1134.
5. Jones, D. B., R. Sexton, and G. Rebell. 1969. Mycotic keratitis in south Florida: a review of thirty-nine cases. Trans. Ophthalmol. Soc. UK 89:781.
6. Jones, D. B., R. K. Forster, and G. Rebell. 1972. Fusarium solani keratitis treated with natamycin (pimaricin): 18 consecutive cases. Arch. Ophthalmol. 88:147.
7. Kalavathy, C. M., P. Parmar, J. Kaliamurthy, V. R. Philip, M. D. Ramalingam, C. A. Jesudasan, and P. A. Thomas. 2005. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis. Cornea 24:449-452.
8. Lalitha, P., B. L. Shapiro, M. Srinivasan, N. V. Prajna, N. R. Acharya, A. W. Fothergil, J. Ruiz, D. Chidambaram, K. J. Maxey, K. C. Hong, S. D. Mcleod, and T. M. Lietman. 2007. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch. Ophthalmol. 125:789-793.
9. Ledbetter, E. C., V. H. Patten, J. M. Scarlett, and F. M. Vermeylen. 2007. In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006). J. Am. Vet. Med. Assoc. 231:1086-1091.
10. Reference deleted.
11. Rosa, R. H., Jr., D. Miller, and E. C. Alfonso. 1994. The changing spectrum of fungal keratitis in South Florida. Ophthalmology 101:1005-1013.
12. Srinivasan, M. 2004. Fungal keratitis. Curr. Opin. Ophthalmol. 15:321-327.
13. Thomas, P. A. 2003. Current perspectives on ophthalmic mycoses. Clin. Microbiol. Rev. 16:730-797.
14. Thylefors, B. 1992. Epidemiological patterns of ocular trauma. Aust. N. Z. J. Ophthalmol. 20:95-98.
15. Whitcher, J. P., and M. Srinivasan. 1997. Corneal ulceration in the developing world: a silent epidemic. Br. J. Ophthalmol. 81:622-623.
16. Xie, L., X. Dong, and W. Shi. 2001. Treatment of fungal keratitis by penetrating keratoplasty. Br. J. Ophthalmol. 85:1070-1074.
17. Xuguang, S., W. Zhixin, W. Zhiqun, L. Shiyun, and L. Ran. 2007. Ocular fungal isolates and antifungal susceptibility in northern China. Am. J. Ophthalmol. 143:131-133.